Karina Fog

This inventor holds 13 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 3 EPO patents. Top assignee: H. Lundbeck A/s. Active years: 2019-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Karina Fog. Retrieved from https://idiyas.com/inventor/karina-fog

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 13 (Patent Applications = 2)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 1)

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 6.8

ph-index = 8

Forward Citations = 111(Granted Patents)

Company Filing History:

13 out of 513

H. Lundbeck A/s

patents

Years Active: 2019-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11542323 - Agents, uses and methods for the treatment of synucleinopathy (2023-01-03),

2. 11524995 - Agents, uses and methods for the treatment of synucleinopathy (2022-12-13),

3. 11421024 - Agents, uses and methods for the treatment of synucleinopathy (2022-08-23),

4. 11325968 - Alpha-synuclein antibodies (2022-05-10),

5. 10800836 - Agents, uses and methods for the treatment of synucleinopathy (2020-10-13),

6. 10647764 - Agents, uses and methods for the treatment of synucleinopathy (2020-05-12),

7. 10647763 - Agents, uses and methods for the treatment of synucleinopathy (2020-05-12),

8. 10640554 - Agents, uses and methods for the treatment of synucleinopathy (2020-05-05),

9. 10364286 - Monoclonal anti-alpha-synuclein antibodies for preventing tau aggregation (2019-07-30),

10. 10364285 - Antibodies for the treatment of synucleinopathy (2019-07-30),

11. 10358484 - Antibodies for the treatment of synucleinopathy (2019-07-23),

12. 10358483 - Antibodies for the treatment of synucleinopathy (2019-07-23),

13. 10358482 - Antibodies for the treatment of synucleinopathy (2019-07-23),

Title: Karina Fog: Innovator in Synucleinopathy Treatment

Introduction

Karina Fog is a prominent inventor based in Valby, Denmark. She has made significant contributions to the field of medical research, particularly in the treatment of synucleinopathies. With a total of 13 patents to her name, her work is paving the way for innovative therapies in neurodegenerative diseases.

Latest Patents

Among her latest patents, Karina Fog has developed novel monoclonal anti-alpha-synuclein antibodies. These antibodies are designed for the treatment of various synucleinopathies, including Parkinson's disease, Diffuse Lewy Body Disease (DLBD), Lewy body variant of Alzheimer's disease, combined Alzheimer's and Parkinson disease, pure autonomic failure, and multiple system atrophy. This groundbreaking invention holds promise for improving the lives of those affected by these debilitating conditions.

Career Highlights

Karina Fog is currently associated with H. Lundbeck A/S, a leading pharmaceutical company specializing in brain diseases. Her role at Lundbeck allows her to focus on her research and development efforts, contributing to the advancement of treatments for neurological disorders.

Collaborations

Throughout her career, Karina has collaborated with notable colleagues such as Pekka Kallunki and Louise Buur Vesterager. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to impactful discoveries.

Conclusion

Karina Fog's work in the field of synucleinopathy treatment exemplifies the importance of innovation in medical research. Her contributions are vital for the development of effective therapies for neurodegenerative diseases, and her ongoing efforts continue to inspire advancements in this critical area of healthcare.

Profile summary based on public USPTO records.